Semaglutide for PCOS weight loss: what week four actually means

What did @highvibemari actually say?

After four weeks on compounded semaglutide at a weight loss clinic, @highvibemari says she is "officially down 10 pounds," though the math puts her actual loss closer to 1.3 pounds (from 186.7 to 185.4 lbs). She described a week-long illness with fever, sore throat, and body aches, and wondered aloud whether the medication affected her immune system. She also explained the difference between compounded semaglutide and brand-name Ozempic and Wegovy, noting cost and accessibility as the main reasons people choose compounded versions. Pricing at her clinic starts at $275 per month and increases with each dose escalation, totaling roughly $1,200 over four months.

She encouraged followers who haven't lost weight in the first four weeks to stay patient, citing her provider's advice that "sometimes it takes until the second month for the medication to hit."

Does the science back this up?

The core weight-loss mechanism she describes, semaglutide as the active ingredient in both compounded and brand-name products, is scientifically accurate. But several surrounding claims need scrutiny.

On weight loss timing: the STEP 1 trial (Wilding et al., 2021, New England Journal of Medicine) showed significant weight loss emerging by week 12 at therapeutic doses. Early weeks at low starting doses often produce minimal loss, which aligns with her provider's advice about patience. That part checks out.

On immunity: there is no peer-reviewed evidence that semaglutide suppresses immune function or worsens illness severity. A GLP-1 receptor agonist works primarily on pancreatic beta cells, the hypothalamus, and the gut. Some research (Drucker, 2022, Cell Metabolism) suggests GLP-1 receptors exist on immune cells, but clinical evidence for meaningful immunosuppression at standard doses is absent. Her illness was most likely a coincidental respiratory infection.

On compounded vs. brand-name: the FDA has explicitly stated that compounded drugs are not FDA-approved and are not equivalent to brand-name products in terms of verified potency, sterility, or bioavailability. This is a regulatory and safety distinction worth repeating.

What did they get wrong (or right)?

She deserves credit for clarifying that compounded semaglutide and Ozempic "are not the same thing," and for explaining the difference to her audience. That is a more responsible framing than many creators use.

What she got wrong: the "down 10 pounds" claim is a significant overstatement. Her own numbers show a 1.3-pound loss at week four. Ten pounds from her stated starting weight would put her at 176.7, which she never reaches in this video. This kind of rounding error or misstatement in weight-loss content spreads unrealistic expectations fast, especially to a PCOS audience already dealing with slow metabolic response.

Her speculation that semaglutide may have worsened her immune response is unsubstantiated. Presenting it as a genuine possibility to 176,000 viewers without a qualifier is irresponsible, even if she framed it as curiosity. Vaccine hesitancy and medication fear are real issues in wellness communities, and offhand immunosuppression speculation adds noise without evidence.

Her cost breakdown is presented as personal experience, not general advice, which is the right framing. But readers should know pricing for compounded semaglutide varies widely by clinic and region.

What should you actually know?

If you have PCOS and are considering semaglutide, the evidence is genuinely promising but not as simple as TikTok makes it look. A 2023 randomized trial (Elkind-Hirsch et al., Fertility and Sterility) found semaglutide improved weight, androgen levels, and menstrual regularity in women with PCOS, but the study used FDA-approved formulations at studied doses, not compounded versions from variable-quality clinics.

Compounded semaglutide is legal under specific FDA shortage provisions, but the FDA has warned repeatedly about quality control problems including incorrect dosing, contamination, and unlicensed facilities. If you go this route, the facility should be an FDA-registered 503B outsourcing facility, not a basic 503A compounding pharmacy, and certainly not a med-spa with a vial and a needle.

Slow early weight loss on semaglutide is normal and expected. The drug is titrated upward over weeks to reduce side effects. Patience is legitimate advice. Comparing your week-four results to someone else's viral transformation video is a reliable way to quit a treatment that might have actually worked for you.